ANGPTL8’s role in lipid regulation suggests that a continuous rise in its levels can cause dyslipidemia and heightened insulin resistance, exacerbating metabolic stress and contributing to the onset of metabolic disorders such as T2D and DN. Here, ANGPTL8 is linked to liver dysplastic nodule.